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Abstract 
 
Heparin-imprinted synthetic polymer surfaces with the ability to attenuate activation of both the 
complement and the coagulation system in whole blood were successfully produced. Imprinting was 
achieved using a template coated with heparin, a highly sulfated glycosaminoglycan known for its 
anticoagulant properties. The N,N’-diacryloylpiperazine—methacrylic acid copolymers were 
characterized using goniometry, AFM and XPS. The influence of the molecular imprinting process on 
morphology and template rebinding was demonstrated by radioligand binding assays. Surface 
hemocompatibility was evaluated using human whole blood without anticoagulants followed by 
measurement of complement activation markers C3a and sC5b-9 and platelet consumption as a surrogate 
coagulation activation marker. The observed low thrombogenicity of this copolymer combined with the 
attenuation of complement activation induced by the molecular imprint offer potential for the 
development of self-regulating surfaces with important potential clinical applications. We propose a 
mechanism for the observed phenomena based upon the recruitment of endogenous sulfated 
glycosaminoglycans with heparin-like activities.  
 
Keywords: Blood compatibility, Coagulation, Complement, Heparin, Surface modification, Surface 
treatment 
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1. Introduction 
 
Control of blood activation upon interaction with foreign materials is the central issue in the attenuation 
of patient response to implantation or to a process, e.g. dialysis or a cardio-pulmonary bypass, which 
involves direct contact between the defense systems of the blood and structures placed in an internal 
human biological environment [1]. 
 
The initial event that takes place when blood comes into contact with a foreign object involves rapid 
adsorption of proteins to the material surface [2-4]. This, in turn, triggers platelet adhesion and activation 
of the coagulation and complement systems [5, 6]. The ability to design a material that does not provoke 
an adverse host response, and thus possesses good biocompatibility, is important on account of the need 
for vast number of devices for interaction with blood in clinical medicine.  
 
The primary function of the complement system is to defend an organism against pathogens. Complement 
is activated when host recognition molecules encounter non-self structures, e.g. microbial carbohydrates 
or artificial (bio)materials. This leads to activation of the central component, C3, by proteolytic enzyme 
complexes, convertases, into the anaphylatoxin C3a that, together with C5a, activates and recruits 
phagocytes, and C3b that binds to target surfaces and promotes phagocytosis [7]. At host surfaces this 
system is under delicate regulation at multiple steps in order to protect autologous cells from 
complement-mediated damage. Surfaces of non-self origin lack these mechanisms resulting in 
inflammatory reactions that in the case of medical device with large surface areas could be systemic 
without administration of soluble inhibitors, e.g. heparin. 
 
The main event in the coagulation cascade is the enzymatic activation of prothrombin to thrombin by 
factor Xa in complex with factor Va. Thrombin is a potent activator of platelets and cleaves fibrinogen to 
fibrin. The main coagulation inhibitor is the serine protease inhibitor antithrombin (AT), which 
inactivates many of the enzymes in the cascade, the major targets being thrombin and factor Xa. In 
contrast to endogenous surfaces, synthetic surfaces do not possess coagulation inhibitors resulting in an 
increased risk for thrombosis. Heparin coated surfaces overcome this mainly through adsorption of the 
coagulation inhibitor AT, thus enhancing its activity [8]. However, the complexity of the coagulation 
cascade, and the diversity of roles that heparin itself plays in the body, mean that heparin coated surfaces 
might have unexpected in vivo effects [9, 10]. Consequently, surfaces with ‘heparin-like’ functionality, or 
surfaces that can recruit heparin or other sulfated carbohydrates are of considerable interest. We have 
been developing an alternative strategy for controlling the activating properties of a surface by creating 
materials designed to exhibit specific binding but overall moderate affinities for a regulatory target 
molecule such as heparin or other sulfated carbohydrates. In principle, surfaces capable of selectively 
recruiting a patient’s endogenous glycosaminoglycans (GAGs) or administered heparin would provide a 
self-regulating biomaterial. 
 
One strategy for preparing such materials is molecular imprinting [11, 12], a means to produce synthetic 
polymers with antibody-like recognition behavior [13]. The technique utilizes a molecular template to 
direct the three dimensional arrangement of polymerizable structural building blocks (monomers) through 
complex formation [14]. Stabilization of the complexes through polymerization and subsequent removal 
of the template reveals a surface capable of selectively rebinding the template molecular structures or 
analogues thereof. Generally, biomacromolecular templates present challenges to the technique due to the 
difficulties associated with the release of large template structures from a three dimensional polymer 
matrix and the necessity for working in aqueous media [15]. It was envisaged that the use of a water 
compatible polymerization system [16], in conjunction with a surface based imprinting format could 
address these challenges [17-19]. In particular, we reasoned that utilizing heparin as a template would 
produce materials with self-regulating characteristics through recognition of endogenous heparin-like 
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substances. Recent reports of efforts to develop heparin-selective electrochemical sensors using molecular 
imprinting provided further support for the potential of this strategy [20-22]. 
 
2. Materials and Methods 
 
2.1 Preparation of template surfaces 
 
Glass microscope slides (26×76 mm) were immersed overnight in solutions of H2SO4 (aq, 0.1 M) and 
then rinsed sequentially with water and acetone before treatment (45 min, 37 °C) with a solution of (3-
aminopropyl)trimethoxysilane (APTMS, Fluka, >97%) in acetone (5%, v/v). The slides were rinsed with 
acetone and then water before treatment (1 h, 22 °C) with an aqueous solution (pH 5.2 adjusted with 
H2SO4) of heparin (Bioiberica, Barcelona, Spain, mean Mw 12 kDa, 110 IU/mg, 7.5%, w/v) containing 
glutardialdehyde (GA, Merck, 3%, v/v). After incubation, the slides were rinsed with water, dried and 
stored at 8 °C until further use. 
 
2.2 Quantification of heparin bound to template surface  
 
The surface concentration of heparin was determined by Corline Systems AB, Uppsala, Sweden using 
toluidine blue staining. The AT binding capacity of the immobilized heparin, with a Corline™ Heparin 
Surface (CHS) as reference, was determined by a colorimetric assay based on the fact that AT in complex 
with heparin inhibits coagulation factor FXa, performed as described [23]. Briefly, the surfaces were 
incubated with AT, then washed and incubated with FXa (both from Enzyme Research Laboratory Inc., 
South Bend, IN, USA). The remaining FXa in solution was determined using a chromogenic substrate 
specific for FXa (S-2222, Chromogenix, Milano, Italy), thus giving an indirect estimate of the amount of 
bound AT.  
 
2.3 Stability of immobilized heparin surfaces 
 
Template surfaces and CHS references (coated on glass) were incubated with citrate plasma in the 
chamber model described below. After incubation, detection was carried out by incubating aliquots of 
plasma with AT. Thereafter, FXa was added and the amount of active FXa (i.e. that had not been 
inhibited by the complexes formed between AT and the heparin that had detached from the surfaces) was 
determined as described above. 
 
2.4 Synthesis of heparin-imprinted polymer surfaces  
 
Microscope slides were cleaned (5 min, 80 °C) in a series of washing solutions containing 4% NH3 (aq), 
5% H2O2 (aq), 4.5% HCl (aq) and 3.8% H2O2 (aq), then carefully rinsed with water, acetone, dry 
tetrahydrofuran and dry toluene and were immediately transferred into a solution comprised of (3-
methacryloxypropyl)trimethoxysilane (3 mL, Sigma), triethylamine (0.3 mL) and in dry toluene (150 
mL). After 24 h at 22 °C the surfaces were washed with dry toluene, dry tetrahydrofuran and dry acetone, 
and dried. 
 
For a batch of five polymer films, diacryloylpiperazine (288 mg, Fluka, >99%) was dissolved in water 
(400 L) by sonication, and 4.6 L methacrylic acid (MAA, Merck) was added. The solution was sparged 
with nitrogen, 40 L 33% (w/v) ammonium persulfate (Sigma) and TEMED (4 L, 30%, v/v) was added 
and 120 L of the solution was spread between the two surfaces. The monomerized and template surfaces 
were separated using spacers (140 m) cut from teflon membrane filters (Pall Corp., MI, USA). After 
polymerization (16 h), the surfaces were carefully separated by treatment with an aqueous ammonia 
solution (5%, w/v), followed by sequential washes with this solution and then with aqueous 4 M 
Guanidine HCl. The resultant polymers were inspected for completeness of surface coverage, absence of 
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scratches and air bubbles using a light microscope. Reference polymers were synthesized as described 
above, but instead of a heparinized glass template, a clean glass surface was used. The polymer films 
were stored in 20% ethanol at 8 °C for up to 6 months. 
2.5 Heparin adsorption/desorption studies  
 
Polymer surfaces were equilibrated in 20 mM phosphate buffer, pH 7.5 (30 min) before PMMA masks 
(26×76×10 mm containing 8 wells with i.d. 6 mm) were mounted over the polymer slides. The wells were 
incubated with 
3
H-heparin (American Radiolabeled Chemicals Inc., St Louis, MO, USA; 0.4 mCi/mg, 
Mw 6-20 kDa) solutions (100 L, 1 h, 22 °C) in the concentration range 0.75 to 75 g/mL diluted in 
phosphate buffer. Aliquots (50 L) were removed and mixed with scintillation cocktail (Beckman Ready 
Safe
TM
, Sweden, 2 mL) and counted in a liquid scintillation counter (Beckman LS 6000, Sweden). The 
values were normalized to avoid day-to-day variability and the difference between reference and 
imprinted polymers was determined. Seven individual experiments were performed (n=3 to 12 wells). 
Studies were also performed with the competing ligand chondroitin sulfate A from bovine trachea 
(Sigma-Aldrich, St Louis, MO, USA), 75 g/mL or heparin (Bioiberica) in phosphate buffer, were 
incubated together with 7.5µg/mL of 3H-heparin (i.e. the concentration where selective binding was seen 
for the MIP compared to the reference, see section 3.4). 
 
In separate experiments, polymer surfaces (imprinted and reference) were incubated for 45 min at 22°C 
with sodium heparin (Bioiberica, 8 mg/mL in 0.9% NaCl) and washed for 15 min with 0.9% NaCl (aq). 
The degree of desorption of heparin from these surfaces after incubation in plasma was studied as 
described above for immobilized heparin surfaces.  
 
2.6 Heparin treatment of equipment and preparation of blood 
 
All equipment used in contact with blood (the slide chamber, tubes, pipette tips, etc.) was furnished with 
a CHS according to the manufacturer’s recommendations. The surface concentration of heparin was 0.5 
g/cm2, with an AT binding capacity of 2-4 pmol/cm2 [24]. Whole blood (25 mL) from healthy 
volunteers who had received no medication for 10 days was collected in 50 mL Falcon
®
 tubes (Becton 
Dickinson, San José, CA, USA) without the addition of soluble heparin, or other anticoagulants, and was 
used within 5 min in the slide chamber model described below.  
 
2.7 Test surface (slide) chambers  
 
The effect on coagulation and complement activation (below) as well as the leakage of heparin from 
different surfaces (above) was determined using a slide chamber model that consists of a 
polymethylmethacrylate (PMMA) microscope slide–sized two-well tray (well-volume 1.65 mL), each of 
which were filled with 1.3 mL of blood (activation studies) or citrate plasma (heparin release) [25]. 
Thereafter, the test surfaces (template, reference and imprinted polymers, CHS or glass) were attached as 
a lid with clips, creating two circular chambers. The device was rotated for 60 min vertically at 22 rpm in 
a 37 °C water bath. Reference glass surfaces were cleaned in 5% (w/v) ammonium persulfate at 60 °C for 
60 min and rinsed in MilliQ water prior to use. 
 
2.8 Incubation of surfaces with blood  
 
Imprint, reference and glass surfaces, incubated with heparin as above, or with 0.9% NaCl only, and 
heparin surfaces (template and CHS coated onto glass) were exposed to whole blood (without added 
anticoagulants) in the chamber model as described above. After incubation, EDTA was added to a final 
concentration of 10 mM, to terminate further activation of complement and coagulation. The experiment 
was performed seven times (four different donors) with duplicate analyses with similar results. 
2.9 Platelet consumption  
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The platelets remaining in the blood samples were counted using a Coulter A
c
T diff
TM
 hematology 
analyzer (Coulter Corporation, Miami, FL, USA). The blood was centrifuged (10 min, 2200 × g, 4 °C) 
within 30 min. and the plasma stored at -70 °C. 
 
2.10 Complement activation  
 
Complement activation was monitored as the generation of C3a and sC5b-9 complexes in plasma by 
enzyme immuno-assays (EIAs) as described previously [26]. In the C3a assay the monoclonal antibody 
4SD17.3 was used for capture and biotinylated polyclonal rabbit anti-C3a and HRP-conjugated 
streptavidin (Amersham, Little Chalfont, UK) for detection [26]. In the sC5b-9 assay, anti neoC9 
monoclonal antibody aE11 (Diatec AS, Oslo, Norway) was used for capture and polyclonal rabbit anti-C5 
antibodies and HRP-conjugated anti-rabbit immunoglobulin (Dako A/S, Glostrup, Denmark) for 
detection [27]. Zymosan-activated serum served as standard and values are given as ng/mL (C3a) or 
arbitrary units/ml (AU/mL; sC5b-9). 
 
2.11 Physical characterization of polymer surfaces  
 
Surface free energies of the polymer surfaces were determined by contact angle goniometry performed 
with a Krüss G10 goniometer (Krüss Optronic, Hamburg, Germany) fitted with an enclosed thermostated 
cell and interfaced to image-capture software (Drop Shape Analysis 1.00.14.0, Krüss Optronic, Hamburg, 
Germany). For advancing (A) contact angle experiments, measurements of air bubbles (2-8 L) using the 
captive bubble technique were recorded at 20 °C using either doubly distilled water, diiodomethane 
(Fluka, >98%) or ethylene glycol (Sigma, >99%). Surfaces were equilibrated (2 × 50 min) in the solvent 
before contact angle experiment was performed and measurements were carried out with 4-9 bubbles on a 
minimum of two independently prepared surfaces to obtain an average contact value. 
 
Images of reference and imprinted polymers were acquired using an atomic force microscope (AFM, 
TopoMetrix TMX2000 Discoverer Scanning Probe Microscope, ThermoMicroscopes, UK) with a 
70×70×12 m3 tripod piezoelectric scanner. Topography measurements were conducted using “V” 
shaped silicon nitride cantilevers each bearing an integrated standard profile tip (length 200 m, nominal 
spring constant (K) 0.032 N/m; Part. No. 1520-00, ThermoMicroscopes, Santa Clara, CA, USA). 
Topographic imaging was performed in air and aqueous buffer using a closed wet cell, modified to allow 
variable temperature adjustment. Contact mode imaging utilized an applied load and scan rate limited to 
ca. 1 nN and 3 Hz, respectively, to minimize compression and lateral damage to polymer grafts and 
underlying surfaces.  
 
2.12 Statistical treatments 
 
Statistical significance was calculated with Student’s t-test using GraphPad Prism® 3.02 (GraphPad 
Software Inc., San Diego, CA, USA). Data are presented as mean values ± SEM. For blood–based studies 
one-way ANOVA was employed followed by Bonferroni’s multiple comparison test. 
 
3. Results  
 
3.1 Preparation of template surfaces & quantification of heparin bound to template surface 
 
The surface concentration of heparin on the template surface was shown by toluidine staining to be 
0.14±0.01 µg/cm
2
 (121 pmol/cm2) (n=7). The AT binding capacity of the template surface was 
determined to be 4.4±0.2 pmol/cm
2
 compared to the CHS 2.8±0.3 pmol/cm
2
. 
3.2 Stability of heparin bound to template surface: 
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The stability of the immobilized heparin was demonstrated by determining the presence of active heparin-
AT complex, after incubation of the template surface with citrated plasma. The amount of heparin 
released into the plasma from a surface area was determined to be 8.8±1.5 pmol/cm
2
 (n=7).  
 
3.3 Synthesis of heparin-imprinted polymer surfaces  
 
Heparin-imprinted and reference polymers were synthesized according to the strategy summarized in 
Figure 1. Although readily obtained, the yield of surfaces of suitable quality (size) for use in studies 
varied between the heparin-imprinted (40%) and glass reference systems (75%). The polymers were 
brittle in the dry state, which necessitated their storage in aqueous solution. X-ray photoelectron 
spectroscopy studies (XPS, Table 1) confirmed the successful elution of template from the surface, as 
reflected in an S-content of <10 pmol/cm
2
. 
 
Table 1 XPS analysis – elemental composition of polymers# 
 
  Carbon Nitrogen Oxygen Sulfur Total 
Found (Non-imprinted) 69.7 ± 0.3 9.0 ± 0.1 20.5 ± 0.1 0.10 ± 0.1 99.2 
Found (Imprinted) 68.4 ± 0.2 8.7 ± 0.1 22.1 ± 0.1 0.18 ± 0.2 99.2 
#) Performed at Fraunhofer Institute for Interfacial Engineering and Biotechnology 
 
 
3.4 Polymer–heparin binding 
 
Polymer binding characteristics were studied using a radioligand binding assay with 
3
H-heparin (Mw 6-
20 kDa) in the concentration range from 0.75 to 75 g/mL. The imprinted polymer showed higher affinity 
for heparin relative to the reference polymer over a narrow concentration interval. The difference between 
reference and imprinted polymers, the selective binding 23±19 pmol/cm
2
, was statistically significant at a 
heparin concentration of 7.5 g/mL (t-test with unequal variances, p=0.009), where the imprinted and 
reference surfaces bound 340 and 317 pmol/cm
2
, respectively. The presence of chondroitin sulfate (CS) 
(75 μg/mL) resulted in a 33±6 % reduction in heparin binding to the imprinted polymer surface, while the 
same concentration of heparin resulted in a reduction of 39±13 % (n=3). More detailed studies using 
higher concentrations were not possible due to saturation of the surface, and the use of lower 
concentrations was limited by the activity of the radioligand.  
 
3.5 Release of heparin from heparin incubated imprinted and reference polymer surfaces 
 
The polymer surfaces were tested for their ability to release heparin into plasma after saturation with 
heparin. Following incubation with 8 mg/mL heparin, ≈1000-fold more than used for the radioligand 
binding studies, followed by rinsing, the surfaces were then incubated with plasma. The plasma was 
analyzed for heparin content as above. This experiment showed that the amount of heparin released from 
the imprinted polymer, 0.036±0.008 IU/mL (18±4 pmol/cm
2
), was lower than for the reference polymer, 
0.060±0.020 IU/mL (31±10 pmol/cm
2
) (n=7).  
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Fig. 1. Schematic representation of the surface imprinting process. Silica glass slides are reacted with 3-
aminopropyltrimethoxysilane (APTMS) and glutardialdehyde in the presence of heparin to generate the template surface. A 
polymerizable layer is formed on a second slide by treatment with 3-methacryloxypropyl)trimethoxysilane (i). Polymerisation 
of a solution containing methacrylic acid (MAA) and diacryloylpiperidine (DAP) is carried out between the glass slides held at 
a defined distance (140 m) by the use of spacers to generate an imprinted surface (ii). Non-imprinted (reference) surfaces are 
prepared using MAA and DAP but with a non-templated surface. Separation of the upper and lower slides and extensive 
washing exposes the imprinted surface (iii, AFM shown in inset) with a ‘memory’ for heparin. Exposure of imprinted surfaces 
to blood leads to lower complement activation than occurs for the reference surfaces (iv). 
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3.6 Surface contact induced platelet consumption 
 
Imprinted and control polymer surfaces as well as unmodified glass surfaces, after saturation with soluble 
heparin followed by incubation with 0.9 % NaCl or incubated with NaCl only, were tested in the blood 
chamber model. The platelet loss was significantly lower for all polymer surfaces compared to the 
unmodified glass (Figure 2A). There were no significant differences between heparin-imprinted or 
control polymer surfaces in the platelet loss results. Preincubation of the heparin-imprinted surface with 
soluble heparin did not affect the decline in platelet counts (44±11 %). All platelets were consumed after 
contact with glass, regardless of whether or not the glass had been preincubated with soluble heparin. 
 
 
 
Fig. 2. Platelet counts and detection of complement activation products C3a and sC5b-9 complexes after contact between 
whole blood and imprint and control surfaces. The tested surfaces consisted of glass, heparin-imprinted surfaces before (MIP) 
or after (MIP+) saturation with soluble heparin, and reference polymers before (Ref) or after (Ref+) saturation with heparin. 
Panel a: Platelet count after incubation of blood without anticoagulant additives for 1 h in the blood chamber model. 
Complement activation was monitored as the generation of C3a (Panel b) and sC5b-9 complexes (Panel c). Data are presented 
as means ± SEM Panel A five experiments, and Panels B and C seven experiments, each performed in duplicate, using blood 
from four different donors (* p<0.05, *** p<0.001, NS = not significant). 
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3.7 Complement activation upon contact between imprinted surfaces and whole blood 
 
The activation of complement by glass is significant, and provides a meaningful reference for comparison 
with treated glass surfaces [28]. The diacryloylpiperazine-methacrylic acid co-polymer used in this study 
was found to be as potent as unmodified glass with respect to complement activation. This high 
complement activating capacity was efficiently overcome by the heparin imprinting process (Figure 2 B, 
C). Neither the levels of generated C3a nor of sC5b-9 complexes were affected by preincubation with 
soluble heparin. In absolute numbers, 635±75 ng/mL of C3a was generated in blood after contact with 
imprinted surfaces without heparin contact, and 740±155 ng/mL with heparin imprints that had been 
preincubated with heparin (Figure 2B). The corresponding values for reference polymers are 1355±195 
ng/mL, and 1370±90 ng/mL, respectively. Levels of 1155±205 ng/mL were detected in samples that had 
been in contact with glass, and no effect was seen upon preincubation with heparin (data not shown). 
Similar observations but with even greater differences between heparin-imprinted and reference polymer 
surfaces were seen when the end product of the complement cascade, sC5b-9, was measured (Figure 2C). 
The heparin-imprinted surfaces induced the formation of 130±45 AU of sC5b-9 per mL with heparin 
saturation and 140±50 AU/mL without. Corresponding values for the polymer reference were 360±95 
AU/mL and 365±90 AU/mL, respectively. The values detected after contact with glass were 265±60 
AU/mL and did not change upon preincubation with soluble heparin (data not shown).  
 
3.8 Physical characterization of the polymer  
 
Atomic Force Microscopy (AFM) imaging of the polymer films was conducted in water using contact 
mode to establish eventual differences in topography and/or roughness, Figure 3.  
 
 
Fig. 3. Atomic force microscopy of imprinted (a) and non-imprinted (b) surfaces. Topographic imaging was performed in air 
and aqueous buffer using a closed wet cell. Contact mode imaging utilised an applied load and scan rate limited to ca. 1 nN 
and 3 Hz, respectively, to minimize compression and lateral damage to polymer grafts and underlying surfaces. Surface 
roughness data (c) shows significantly higher roughness (t-test, unequal variances) for the imprinted surface than for the 
control.. Adhesion forces (d) of Si3N4 tip-to-surface for both imprinted and non-imprinted surfaces were significantly lower (p 
< 0.001) than for glass and mica (data not shown), but there was no significant adhesion force difference between the 
imprinted and non-imprinted surfaces (p > 0.05).  
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Imprinted and reference polymer surface energies were determined by contact angle goniometry using the 
captive bubble technique [29]. The contact angles (water, diiodomethane and ethylene glycol) and surface 
free energy components were determined, Table 2. Advancing water contact angles, w, for the surfaces 
were determined to be 35.7±0.6 and 34.4±0.9 º, respectively.  
 
Table 2 Advancing contact angles of water, diiodomethane (DIM) and ethylene glycol (EG) on 
polymer surfaces and surface free energies of these systems.  
 
Polymer Contact angle, a (°)# Surface energy (mJ m
-2
)
##
 
 H2O DIM EG S
LW S
+ S
- S
tot 
Ref 36 ± 3 52 ± 2 35 ± 2 33 ± 1 0.1 ± 0 54 ± 3 39 ± 1 
MIP 34 ± 5 61 ± 2 42 ± 2 28 ± 1 0.1 ± 0 63 ± 4 34 ± 1 
 
#) Each contact angle value is the mean of at least four bubbles on a minimum of two independently 
prepared polymer samples. ##) Differences between S
LW
,
 S
-
 and S
tot 
were all statistically significant (p < 
0.05) as determined by t-test (two-sample assuming unequal variances). 
 
4. Discussion 
 
Full blood compatibility requires that the surface in contact activates neither coagulation nor complement 
cascades. While heparinization, which is always optimized for minimizing coagulation rather than 
complement activation [30], has been used for decades to produce surfaces with minimal activating 
character, alternatives not relying on the use of substances of biological origin are most desirable. We 
envisaged that a surface capable of recruiting exogenous heparin (or endogenous analogues such as 
chondroitin sulfate (CS) or serglycin) from a patients’ own blood during an extra-corporal procedure such 
as during coronary-pulmonary bypass surgery should have the possibility to be self-regulating thus 
diminishing the risk of thrombosis.  
 
Molecular imprinting [11, 12] was perceived as a means to produce surfaces with such self-regulatory 
function. However, to achieve imprinted polymer surfaces capable of recognizing heparin in its 
biologically active conformation necessitates a polymerization system amenable to use in aqueous media 
and capable of supporting monomer-template interactions while not compromising the three dimensional 
structure of the macromolecular template. Polymers comprised of diacryloylpiperazine and methacrylic 
acid have previously been demonstrated to be suitable for imprinting in aqueous media [16]. However, 
the physical size of a macromolecular structure such as heparin prohibits its use in conjunction with 
established imprinting strategies (bulk polymerization) on account of the difficulties associated with the 
removal of the template from the polymer. To avoid this problem, and in order to have a material to 
which blood proteins have access a surface imprinting strategy was adopted, Figure 1. Whitcombe and 
colleagues have described the preparation of quasi-2-dimensional surface imprints (a textured 2-D 
polymer surface) of inorganic materials [17], and a related approach has been adopted by the groups of 
Ratner [19] and Shea [18] for proteins and peptides. Heparin-derivatized template surfaces were prepared 
with a surface concentration of 121 pmol/cm2. The theoretical surface loading (close packing) of heparin 
(mean Mw 12 kDa) was estimated to 7 pmol/cm
2
 based on the heparin structure determined from NMR 
studies by Mulloy et al. [31] and the assumptions that all heparin molecules lie flat on the surface and that 
charge repulsion does not influence packing density. A higher packing density indicates that portions of 
the heparin structure are free in solution, i.e. that on average only a portion of each heparin molecule is 
physically bound to the derivatized surface, a process driven by repulsive coulombic interactions. 
 
The conformation of immobilized heparin is critical, i.e. that the active pentasaccharide is exposed and 
can bind AT. The quality of the template surface was therefore determined by the efficiency of which AT 
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bound to the surface bound heparin (4.40.2 pmol/cm2), and was found to be comparable to that of 
commercial heparin surfaces (2.80.3 pmol/cm2). The stability of the immobilized heparin upon contact 
with plasma was reflected in the very low level of soluble heparin-AT complex, 8.8±1.5 pmol/cm
2
. This 
value, close to the detection limit of the assay, indicates that the template surface is as stable as the 
reference CHS, i.e. with no leakage of heparin into the blood [32]. 
 
Imprinted and reference polymer surfaces were synthesized following the strategy depicted in Figure 1. 
Importantly, imprinted surfaces were shown by XPS to have no significant concentration of residual 
heparin. Radioligand binding studies revealed that the imprinted polymer surfaces had greater affinity for 
heparin, a function that could be attenuated by the presence of the endogenous GAG CS.  
 
These studies using whole blood demonstrate that the influence of the heparin template on the polymer 
resulted in a surface capable of attenuating complement activation, as determined through studying two 
separate points in this cascade system. Furthermore, as pre-incubation of surfaces with soluble heparin 
did not influence complement activation, it must be concluded that the specific characteristics of the 
heparin molecularly imprinted polymer surface are directly responsible for the biological activity of the 
surface. In studies using surfaces pre-incubated with heparin, the amount of heparin released from the 
imprinted polymer, 0.036±0.008 IU/mL, was lower than for the reference polymer, 0.060±0.020 IU/mL, 
indicating that heparin is bound more strongly to the imprinted surface than to the reference. This was 
supported by the results of XPS studies. This concentration can be compared to the patient blood 
concentration normally employed during bypass surgery (up to 3 IU/mL) [33]. Moreover, since the 
amount of heparin released from the surfaces is very low, the effect seen on C3a and sC5b-9 
measurements cannot be a result of heparin leaking since no effect on complement activation is seen at 
concentrations of heparin below 0.5 IU/mL [34]. Importantly, the diacryloylpiperazine-methacrylic acid 
co-polymer has an inherently low thrombogenicity, which when coupled with the relatively low 
complement activating character induced by the molecular imprinting process renders a material with 
enhanced hemocompatibility.  
 
Unraveling the mechanisms underlying the unique behavior of the imprinted polymer films when in 
contact with blood is challenging. As heparin is not an endogenous component of blood an important 
question arises, namely, to what component(s) present in blood can we attribute the observed differences 
in the hemocompatibility of the two surfaces? The main proteoglycan present in all blood cells consists of 
the protein serglycine, decorated with multiple CS chains [35]. The concentration of CS in plasma has 
been demonstrated to increase by 4µg/mL upon platelet activation [28]. We hypothesize that the 
interaction of the polymers with this complex endogenous proteo-GAG provides the basis for the 
differences in degree of complement activation of the two surfaces. This is supported by the capacity of 
CS to attenuate the binding of radiolabeled heparin to the imprinted polymer surface. Indeed, incubation 
of imprinted surfaces with radiolabeled heparin in the presence or absence of CS demonstrated CS 
recognition by the imprint surface. Moreover, we propose a role for the glycosaminoglycan serglycin in 
the observed compatibility of the molecularly imprinted surfaces with the complement cascade. Yoshimi 
et al. [20] have reported the synthesis of bulk imprinted (2-(methacryloxy)-ethyl)trimethylammonium 
chloride acrylamide – acrylamide – N,N´-methylenebisacrylamide copolymer films for electrochemical 
detection of heparin over the concentration range 0.05-0.5 g/mL. In the present study we have been able 
to probe concentration ranges down to the pM domain through the bioassays deployed here. The reported 
presence of higher sulfur-levels, i.e. residual heparin, on the polymer coated electrodes makes direct 
comparisons with the surface template materials reported in the present study difficult. This was reported 
to arise from the covalent immobilization or network-entrapment of the template, factors motivating the 
use of surface templating strategies. However, the selectivity for heparin, or lack of selectivity for CS, 
they reported is in contrast to the suppression of heparin binding by CS seen when working with the 
polymer systems used here. We attribute this to the significantly greater number of charged sulphated 
residues in heparin relative to CS that results in a significant difference in the numbers of strong ion-
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pairing interactions with the quaternary ammonium ion between the ligands and polymer-coated 
electrode, though even morphological features could contribute. A similar heparin detection range was 
reported by Li et al. [21] using a methacrylic acid - ethyleneglycol dimethacrylate copolymer, again 
prepared by bulk polymerization rather than the surface templating approach used here.  
 
In view of the known activation of the coagulation cascade via contact of blood with synthetic surfaces 
[36], surfaces were investigated using AFM in order to establish if there were any marked differences in 
topography and/or roughness of imprinted surfaces compared to controls, Figure 3. Importantly, there 
were no significant differences in the overall topographies at the micron scale and both polymer films 
displayed features corresponding to interconnected agglomerates (~50-75 nm in diameter), spaced evenly 
across the surface. These agglomerates were indicative of the macroporous polymer structure formed by 
cross-linking in a porogenic solvent. Separation of the polymer aggregates was <10 nm. Further analysis 
indicated a marginally increased overall roughness in the case of the heparin-imprinted polymer surface, 
than in the case of the reference polymer, with a difference in height over the areas studied of ±1nm for 
the imprinted surfaces than for the control polymer. Generally speaking, complement activation is 
proportional to blood accessible surface area. In this case, the imprinted polymer surface was less 
complement activating than the reference, as reflected by the observed levels of sC5b-9 and C3a , despite 
a greater apparent surface area. Together with the platelet consumption and complement activation 
studies, this data provides further support for the role of the heparin template induced influence on 
polymer structure on the behavior of the imprinted polymer when in contact with blood.  
 
In an attempt to determine the influence of the template surface on the corresponding polymer at a higher 
level of chemical detail, the surface free energies of reference and imprinted materials were determined 
by contact angle goniometry using the captive bubble technique [29]. The contact angles for water, 
diiodomethane and ethylene glycol as well as the surface free energy components were determined, Table 
2. The advancing water contact angle, w, for the reference and imprinted surfaces indicated that both 
surfaces were similar with respect to hydrophilic character. The hydrophilic nature of the material itself 
may explain the strong complement activation seen when presented to blood in the absence of a heparin 
surface imprint [37]. 
 
Examination of the Lewis base and Lifschitz van der Waals components revealed noticeable differences 
between reference and imprinted polymers, suggesting a higher electron pair density at the imprinted 
surface. This may be explained by an enrichment of methacrylic acid residues (reported as carboxylates 
during contact angle measurements at pH 7) at the imprinted surface through prior binding to polar and 
hydrogen bonding sites on the heparin chain during the templated polymerization. The methacrylic acid 
residues were likely to have been non-ionized during the initial imprinting, but would have been 
converted to carboxylates during contact angle studies in distilled water: the Lewis base content thus 
reports the relative surface content of these residues. Similarly, the localized higher polarity of the 
imprinted surface was confirmed through the reduced van der Waals’ component compared to the non-
imprinted material. The low magnitude of the Lewis acid components for both surfaces suggested that 
residual non-ionized carboxylic acid functionality contributed little to the measured total surface energy 
during contact angle analysis. The total surface free energies of the polymer films were determined to be 
39 mJ/m
2
 for the reference and 34 mJ/m
2
 for the imprinted surface, which are similar to those obtained 
for other polyacrylamides [38]. The indication of functionalities complementary to the template, and 
especially their surface enrichment, provides further support for the presence of sites with selectivity for 
an active form of heparin or similar sulfated polysaccharides, such as serglycine, on the surface of the 
imprinted polymers.  
 
Collectively, these data provide strong support for the presence of heparin selective sites in the 
molecularly imprinted polymer film. These results suggest the use of molecularly imprinted polymer 
films as potential autoregulatory surface coatings for materials to be placed in contact with blood.  
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5. Conclusions 
 
The capacity to attenuate complement cascade activation with heparin molecularly imprinted surfaces 
provides the first example of the design and fabrication of synthetic self-regulating surfaces for the 
attenuation of biological responses in blood. The results presented here offer significant potential for 
clinical use due to the demonstrated suppression of thromboinflammatory processes. The use of surface 
molecular imprinting protocols in conjunction with polymers compatible with aqueous systems offers 
further possibilities for the regulation of biological processes with biomimetic materials. The stability of 
these materials, e.g. to autoclave sterilization [39], offers particular advantages with respect to their use in 
medical device development. Furthermore, the use of whole blood systems for the evaluation of 
biomaterials provides a holistic perspective of significance for eventual clinical applications.  
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